Cubist Systematic Strategies’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.55M | Buy |
+396,586
| New | +$5.55M | 0.03% | 451 |
|
|
2024
Q1 | – | Sell |
-77
| Closed | -$1.65K | – | 2377 |
|
|
2023
Q4 | $1.65K | Buy |
+77
| New | +$1.65K | ﹤0.01% | 2031 |
|
|
2023
Q3 | – | Sell |
-26,642
| Closed | -$786K | – | 2118 |
|
|
2023
Q2 | $786K | Sell |
26,642
-65,164
| -71% | -$1.92M | 0.01% | 1248 |
|
|
2023
Q1 | $2.12M | Buy |
91,806
+86,966
| +1,797% | +$2M | 0.01% | 1091 |
|
|
2022
Q4 | $135K | Sell |
4,840
-33,501
| -87% | -$932K | ﹤0.01% | 2784 |
|
|
2022
Q3 | $1.18M | Sell |
38,341
-33,563
| -47% | -$1.03M | 0.01% | 1950 |
|
|
2022
Q2 | $2.12M | Buy |
71,904
+55,735
| +345% | +$1.64M | 0.01% | 1525 |
|
|
2022
Q1 | $520K | Buy |
16,169
+8,303
| +106% | +$267K | ﹤0.01% | 2493 |
|
|
2021
Q4 | $351K | Sell |
7,866
-1,740
| -18% | -$77.6K | ﹤0.01% | 2694 |
|
|
2021
Q3 | $485K | Sell |
9,606
-5,462
| -36% | -$276K | 0.01% | 2057 |
|
|
2021
Q2 | $1.18M | Sell |
15,068
-68,573
| -82% | -$5.38M | 0.01% | 1444 |
|
|
2021
Q1 | $4.78M | Buy |
83,641
+62,192
| +290% | +$3.55M | 0.06% | 480 |
|
|
2020
Q4 | $1.8M | Sell |
21,449
-66,120
| -76% | -$5.54M | 0.02% | 1016 |
|
|
2020
Q3 | $3.14M | Buy |
87,569
+66,979
| +325% | +$2.4M | 0.05% | 636 |
|
|
2020
Q2 | $498K | Sell |
20,590
-2,909
| -12% | -$70.4K | 0.01% | 1591 |
|
|
2020
Q1 | $411K | Buy |
+23,499
| New | +$411K | 0.01% | 1348 |
|
|
2019
Q2 | – | Sell |
-20,840
| Closed | -$484K | – | 2476 |
|
|
2019
Q1 | $484K | Buy |
+20,840
| New | +$484K | 0.02% | 1217 |
|
|
2018
Q1 | – | Sell |
-11,775
| Closed | -$184K | – | 1882 |
|
|
2017
Q4 | $184K | Buy |
+11,775
| New | +$184K | 0.01% | 1555 |
|